ESR1 and breast carcinoma: Here, we focus a discussion of these issues with respect to a particular group of poor prognosis human breast cancers within those historically classified pathologically as “triple-negative” due to the lack of expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2).